摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-thioxo-2,3-dihydro-benzothiazole-5-sulfonic acid | 23015-22-7

中文名称
——
中文别名
——
英文名称
2-thioxo-2,3-dihydro-benzothiazole-5-sulfonic acid
英文别名
2-Thioxo-2,3-dihydro-benzothiazol-5-sulfonsaeure;2-Sulfanyl-1,3-benzothiazole-5-sulfonic acid;2-sulfanylidene-3H-1,3-benzothiazole-5-sulfonic acid
2-thioxo-2,3-dihydro-benzothiazole-5-sulfonic acid化学式
CAS
23015-22-7
化学式
C7H5NO3S3
mdl
——
分子量
247.32
InChiKey
YOPUIFSTGVXMLL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.88±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    132
  • 氢给体数:
    2
  • 氢受体数:
    5

SDS

SDS:0be818f62690d52abb9f07058e432f9b
查看

反应信息

点击查看最新优质反应信息

文献信息

  • LITHOGRAPHIC PRINTING PLATE PRECURSOR AND LITHOGRAPHIC PRINTING PROCESS
    申请人:OOHASHI Hidekazu
    公开号:US20110054212A1
    公开(公告)日:2011-03-03
    A lithographic printing plate precursor, which comprises: a support; an image-recording layer; and a protective layer, in this order, wherein at least one of the image-recording layer and the protective layer comprises a phosphonium salt having a specific structure, and a lithographic printing process, which comprises: exposing a lithographic printing plate precursor; supplying an oil-based ink and a fountain solution comprising a phosphonium salt having a specific structure to the exposed lithographic printing plate precursor on a printing machine to remove an unexposed area of an image-recording layer; and conducting printing.
    一种光刻印刷版前体,包括:支撑体;图像记录层;以及保护层,依次排列,其中图像记录层和保护层中至少有一层包含具有特定结构的磷酸铵盐;以及一种光刻印刷工艺,包括:曝光光刻印刷版前体;在印刷机上向曝光的光刻印刷版前体提供具有特定结构的磷酸铵盐的油墨和喷泉溶液,以去除图像记录层中未曝光区域;进行印刷。
  • Lithographic printing plate precursor and lithographic printing process
    申请人:Fuji Photo Film Co., Ltd.
    公开号:EP1754597A2
    公开(公告)日:2007-02-21
    A lithographic printing plate precursor, which comprises: a support; an image-recording layer; and a protective layer, in this order, wherein at least one of the image-recording layer and the protective layer comprises a phosphonium salt having a specific structure, and a lithographic printing process, which comprises: exposing a lithographic printing plate precursor; supplying an oil-based ink and a fountain solution comprising a phosphonium salt having a specific structure to the exposed lithographic printing plate precursor on a printing machine to remove an unexposed area of an image-recording layer; and conducting printing.
    一种平版印刷板前体,它依次包括:支撑物;图像记录层;和保护层,其中图像记录层和保护层中的至少一个包括具有特定结构的膦盐,以及一种平版印刷工艺,它包括:曝光平版印刷板前体;在印刷机上向曝光的平版印刷板前体提供油基油墨和包含具有特定结构的鏻盐的润版液,以去除图像记录层的未曝光区域;以及进行印刷。
  • Methods and apparatus for accelerated orthokeratology
    申请人:——
    公开号:US20010016731A1
    公开(公告)日:2001-08-23
    An accelerated method of orthokeratology includes the steps of softening of the cornea with a softening agent, applying a mold to reshape the cornea to a desired anterior curvature, and rapidly restabilizing or “fixing” the corneal tissues so that the cornea retains its new configuration. A chemical softening agent, such as glutaric anhydride is applied to the cornea to soften the cornea, after which a specially designed mold of predetermined curvature and configuration is applied to the cornea. Slight downward pressure is applied to the mold for a predetermined period of time to re-shape the cornea. The mold is maintained in position while a stabilizing agent, such as a UV light source, is positioned above the mold. The stabilizing agent, i.e. UV light, is applied to the cornea for a predetermined time, wherein the stabilizing agent immediately restabilizes the corneal tissue so that the cornea immediately retains its shape upon removal of the mold. The stabilization process can also be used for patients having already undergone traditional orthokeratology to eliminate the need to continue wearing a retainer to maintain the shape of the cornea.
    角膜矫形术的加速方法包括以下步骤:用软化剂软化角膜,使用模具将角膜重塑成所需的前弧度,并迅速重新稳定或 "固定 "角膜组织,使角膜保持新的形态。在角膜上涂抹化学软化剂(如戊二酸酐)以软化角膜,然后在角膜上涂抹专门设计的具有预定弧度和结构的模具。在预定时间内对模具施加轻微的向下压力,以重新塑形角膜。将稳定剂(如紫外线光源)置于模具上方时,模具将保持在原位。将稳定剂(即紫外线)照射到角膜上,持续预定的时间,其中稳定剂会立即重新稳定角膜组织,使角膜在移除模具后立即保持其形状。稳定过程也可用于已接受传统角膜矫形术的患者,使其无需继续佩戴保持器来保持角膜的形状。
  • DE615132
    申请人:——
    公开号:——
    公开(公告)日:——
  • METHODS AND APPARATUS FOR ACCELERATED ORTHOKERATOLOGY
    申请人:Ista Pharmaceuticals, Inc.
    公开号:EP1051655A1
    公开(公告)日:2000-11-15
查看更多

同类化合物

(1Z)-1-(3-乙基-5-羟基-2(3H)-苯并噻唑基)-2-丙酮 齐拉西酮砜 阳离子蓝NBLH 阳离子荧光黄4GL 锂2-(4-氨基苯基)-5-甲基-1,3-苯并噻唑-7-磺酸酯 铜酸盐(4-),[2-[2-[[2-[3-[[4-氯-6-[乙基[4-[[2-(硫代氧代)乙基]磺酰]苯基]氨基]-1,3,5-三嗪-2-基]氨基]-2-(羟基-kO)-5-硫代苯基]二氮烯基-kN2]苯基甲基]二氮烯基-kN1]-4-硫代苯酸根(6-)-kO]-,(1:4)氢,(SP-4-3)- 铜羟基氟化物 钾2-(4-氨基苯基)-5-甲基-1,3-苯并噻唑-7-磺酸酯 钠3-(2-{(Z)-[3-(3-磺酸丙基)-1,3-苯并噻唑-2(3H)-亚基]甲基}[1]苯并噻吩并[2,3-d][1,3]噻唑-3-鎓-3-基)-1-丙烷磺酸酯 邻氯苯骈噻唑酮 西贝奈迪 螺[3H-1,3-苯并噻唑-2,1'-环戊烷] 螺[3H-1,3-苯并噻唑-2,1'-环己烷] 葡萄属英A 草酸;N-[1-[4-(2-苯基乙基)哌嗪-1-基]丙-2-基]-2-丙-2-基氧基-1,3-苯并噻唑-6-胺 苯酰胺,N-2-苯并噻唑基-4-(苯基甲氧基)- 苯酚,3-[[2-(三苯代甲基)-2H-四唑-5-基]甲基]- 苯胺,N-(3-苯基-2(3H)-苯并噻唑亚基)- 苯碳杂氧杂脒,N-1,2-苯并异噻唑-3-基- 苯甲基2-甲基哌啶-1,2-二羧酸酯 苯并噻唑正离子,2-[3-(1,3-二氢-1,3,3-三甲基-2H-吲哚-2-亚基)-1-丙烯-1-基]-3-乙基-,碘化(1:1) 苯并噻唑正离子,2-[(2-乙氧基-2-羰基乙基)硫代]-3-甲基-,溴化 苯并噻唑啉 苯并噻唑-d4 苯并噻唑-6-腈 苯并噻唑-5-羧酸 苯并噻唑-5-硼酸频哪醇酯 苯并噻唑-4-醛 苯并噻唑-4-乙酸 苯并噻唑-2-磺酸钠 苯并噻唑-2-磺酸 苯并噻唑-2-磺酰氟 苯并噻唑-2-甲醛 苯并噻唑-2-甲酸 苯并噻唑-2-甲基甲胺 苯并噻唑-2-基磺酰氯 苯并噻唑-2-基叠氮化物 苯并噻唑-2-基-邻甲苯-胺 苯并噻唑-2-基-己基-胺 苯并噻唑-2-基-(4-氯-苯基)-胺 苯并噻唑-2-基-(4-氟-苯基)-胺 苯并噻唑-2-基-(4-乙氧基-苯基)-胺 苯并噻唑-2-基-(2-甲氧基-苯基)-胺 苯并噻唑-2-基-(2,6-二甲基-苯基)-胺 苯并噻唑-2-基(对甲苯基)甲醇 苯并噻唑-2-乙酸甲酯 苯并噻唑-2-乙腈 苯并噻唑-2(3H)-酮N2-[1-(吡啶-4-基)乙亚基]腙 苯并噻唑-2 - 丙基 苯并噻唑,6-(3-乙基-2-三氮烯基)-2-甲基-(8CI)